-
1
-
-
0004307465
-
-
United States Patent 5145,684
-
G.G. Liversidge, K.C. Cundy, J.F. Bishop, D.A. Czekai, Surface modified drug nanoparticles, United States Patent 5145,684, 1992.
-
(1992)
Surface Modified Drug Nanoparticles
-
-
Liversidge, G.G.1
Cundy, K.C.2
Bishop, J.F.3
Czekai, D.A.4
-
4
-
-
9044235775
-
Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs
-
DOI 10.1023/A:1016051316815
-
E. Merisko-Liversidge, P. Sarpotdar, J. Bruno, S. Hajj, L. Wei, N. Peltier, J. Rake, J.M. Shaw, S. Pugh, L. Polin, J. Jones, T. Corbett, E. Cooper, and G.G. Liversidge Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs Pharm. Res. 13 1996 272 278 (Pubitemid 26074194)
-
(1996)
Pharmaceutical Research
, vol.13
, Issue.2
, pp. 272-278
-
-
Merisko-Liversidge, E.1
Sarpotdar, P.2
Bruno, J.3
Hajj, S.4
Wei, L.5
Peltier, N.6
Rake, J.7
Shaw, J.M.8
Pugh, S.9
Polin, L.10
Jones, J.11
Corbett, T.12
Cooper, E.13
Liversidge, G.G.14
-
5
-
-
0028824401
-
Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats
-
G.G. Liversidge, and P. Conzentino Drug particle size reduction for decreasing gastric irritancy and enhancing absorption of naproxen in rats Int. J. Pharm. 125 1995 309 313
-
(1995)
Int. J. Pharm.
, vol.125
, pp. 309-313
-
-
Liversidge, G.G.1
Conzentino, P.2
-
6
-
-
0029080002
-
Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs
-
G.G. Liversidge, and K.C. Cundy Particle size reduction for improvement of oral bioavailability of hydrophobic drugs: I. Absolute oral bioavailability of nanocrystalline danazol in beagle dogs Int. J. Pharm. 125 1995 91 97
-
(1995)
Int. J. Pharm.
, vol.125
, pp. 91-97
-
-
Liversidge, G.G.1
Cundy, K.C.2
-
7
-
-
4544383493
-
Nanosuspensions in drug delivery
-
DOI 10.1038/nrd1494
-
B.E. Rabinow Nanosuspensions in drug delivery Nat. Rev. Drug Discov. 3 2004 785 796 (Pubitemid 39242830)
-
(2004)
Nature Reviews Drug Discovery
, vol.3
, Issue.9
, pp. 785-796
-
-
Rabinow, B.E.1
-
8
-
-
77956882799
-
Nanocrystals: Industrially feasible multifunctional formulation technology for poorly soluble actives
-
R. Shegokar, and R.H. Müller Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives Int. J. Pharm. 399 2010 129 139
-
(2010)
Int. J. Pharm.
, vol.399
, pp. 129-139
-
-
Shegokar, R.1
Müller, R.H.2
-
9
-
-
79953162538
-
State of the art of nanocrystals - Special features, production, nanotoxicology aspects & intracellular delivery
-
R.H. Müller, S.H. Gohla, and C.M. Keck State of the art of nanocrystals - special features, production, nanotoxicology aspects & intracellular delivery Eur. J. Pharm. Biopharm. 78 2011 1 9
-
(2011)
Eur. J. Pharm. Biopharm.
, vol.78
, pp. 1-9
-
-
Müller, R.H.1
Gohla, S.H.2
Keck, C.M.3
-
10
-
-
0036176196
-
Production and characterization of a budesonide nanosuspension for pulmonary administration
-
DOI 10.1023/A:1014276917363
-
C. Jacobs, and R.H. Müller Production and characterization of a budesonide nanosuspension for pulmonary administration Pharm. Res. 19 2002 189 194 (Pubitemid 34165405)
-
(2002)
Pharmaceutical Research
, vol.19
, Issue.2
, pp. 189-194
-
-
Jacobs, C.1
Muller, R.H.2
-
12
-
-
34250879747
-
Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat
-
DOI 10.1016/j.ijpharm.2007.02.030, PII S0378517307002062
-
B. Rabinow, J. Kipp, P. Papadopoulos, J. Wong, J. Glosson, J. Gass, C.S. Sun, T. Wielgos, R. White, C. Cook, K. Barker, and K. Wood Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat Int. J. Pharm. 339 2007 251 260 (Pubitemid 46977603)
-
(2007)
International Journal of Pharmaceutics
, vol.339
, Issue.1-2
, pp. 251-260
-
-
Rabinow, B.1
Kipp, J.2
Papadopoulos, P.3
Wong, J.4
Glosson, J.5
Gass, J.6
Sun, C.-S.7
Wielgos, T.8
White, R.9
Cook, C.10
Barker, K.11
Wood, K.12
-
13
-
-
37549041747
-
Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement
-
L. Gao, D. Zhang, M. Chen, T. Zheng, and S. Wang Preparation and characterization of an oridonin nanosuspension for solubility and dissolution velocity enhancement Drug Dev. Ind. Pharm. 33 2007 1332 1339
-
(2007)
Drug Dev. Ind. Pharm.
, vol.33
, pp. 1332-1339
-
-
Gao, L.1
Zhang, D.2
Chen, M.3
Zheng, T.4
Wang, S.5
-
14
-
-
33644799822
-
Characterization of nebulized buparvaquone nanosuspensions - Effect of nebulization technology
-
DOI 10.1080/10611860500353245, PII L78743176142486
-
N. Hernandez-Trejo, O. Kayser, H. Steckel, and R.H. Müller Characterization of nebulized buparvaquone nanosuspensions - effect of nebulization technology J. Drug Target. 13 2005 499 507 (Pubitemid 43347847)
-
(2005)
Journal of Drug Targeting
, vol.13
, Issue.8-9
, pp. 499-507
-
-
Hernandez-Trejo, N.1
Kayser, O.2
Steckel, H.3
Muller, R.H.4
|